Literature DB >> 16733108

Cardiopulmonary complications of ERCP in older patients.

Leon Fisher1, Alexander Fisher, Andrew Thomson.   

Abstract

BACKGROUND: Biochemical markers of ERCP-related myocardial injury have not previously been investigated.
OBJECTIVE: To evaluate ERCP-related cardiac troponin I (cTnI) release, myocardial ischemia, hemodynamic changes, and arterial hypoxemia in a series of consecutive patients according to age and to determine their relationship to preexisting cardiovascular risk factors (RF) and the development of post-ERCP pancreatitis.
DESIGN: Prospective cohort study.
SETTING: Tertiary teaching hospital, Canberra, Australia. PATIENTS: Data were collected on 130 consecutive ERCPs performed on 100 unselected patients (aged 18-93 years) by one endoscopist. Patients were divided into two groups: 65 years of age and older (group 1, n = 53; 27 women) and less than 65 years of age (group 2, n = 47; 33 women).
INTERVENTIONS: ERCP. MAIN OUTCOME MEASUREMENTS: Cardiovascular RFs were identified, and electrocardiogram (ECG), cTnI, creatine kinase (CK), amylase, and lipase were measured before and 24 hours after ERCP. Oxygen saturation (SpO(2)), heart rate (HR), blood pressure (BP), and ECG were monitored continuously during each procedure.
RESULTS: New ECG changes (ischemia, arrhythmias) occurred in 24% of procedures in group 1 and in 9.3% in group 2 (p = 0.168), and episodic arterial hypoxemia (SpO(2) < 90%) in 16.2% (group 1) and 21.4% (group 2) (p = 0.596). A post-ERCP rise in cTnI levels was documented in 6 patients in the older group. Two of these patients died: one from acute myocardial infarction and one from undiagnosed ascending aortic aneurysm. A cTnI rise was not related to any comorbid conditions, total number of RFs, hemodynamic or ECG changes, or arterial desaturation. In patients with a new cTnI rise, the duration of ERCP was significantly longer (59.5 vs. 26.4 minutes, p = 0.026), being 30 minutes or longer in 5 of 6 patients. Post-ERCP pancreatitis was associated with desaturation (relative risk [RR] = 5.9; 95% confidence interval [CI] [1.2, 32.0], p = 0.027) and myocardial ischemia/injury (RR = 4.4; 95% CI [1.4, 7.8]; p = 0.009).
CONCLUSIONS: Although the majority of older patients tolerated ERCP well, in 8% of procedures, most of which were prolonged (>30 minutes), myocardial injury, as defined by the release of cTnI, occurred. Desaturation and myocardial ischemia/injury were associated with post-ERCP pancreatitis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16733108     DOI: 10.1016/j.gie.2005.09.020

Source DB:  PubMed          Journal:  Gastrointest Endosc        ISSN: 0016-5107            Impact factor:   9.427


  21 in total

1.  Transnasal endoscopic retrograde chalangiopancreatography using an ultrathin endoscope: a prospective comparison with a routine oral procedure.

Authors:  Akihiro Mori; Noritsugu Ohashi; Takako Maruyama; Hideharu Tatebe; Katsuhisa Sakai; Takashi Shibuya; Hiroshi Inoue; Shoudou Takegoshi; Masataka Okuno
Journal:  World J Gastroenterol       Date:  2008-03-14       Impact factor: 5.742

2.  Risk factors for hypoxemia during ambulatory gastrointestinal endoscopy in ASA I-II patients.

Authors:  Mohammed A Qadeer; A Rocio Lopez; John A Dumot; John J Vargo
Journal:  Dig Dis Sci       Date:  2008-11-12       Impact factor: 3.199

3.  Managing risks related to ERCP in elderly patients with difficult bile duct stones.

Authors:  Gilmara Coelho Meine; Todd H Baron
Journal:  Dig Dis Sci       Date:  2014-08-09       Impact factor: 3.199

4.  Safety and efficacy of etomidate and propofol anesthesia in elderly patients undergoing gastroscopy: A double-blind randomized clinical study.

Authors:  Qing-Tao Meng; Chen Cao; Hui-Min Liu; Zhong-Yuan Xia; Wei Li; Ling-Hua Tang; Rong Chen; Meng Jiang; Yang Wu; Yan Leng; Chris C Lee
Journal:  Exp Ther Med       Date:  2016-06-24       Impact factor: 2.447

5.  Endoscopic and anesthetic feasibility of EUS and ERCP combined in a single session versus two different sessions.

Authors:  Juan J Vila; Marcos Kutz; Silvia Goñi; Miriam Ostiz; Edurne Amorena; Carlos Prieto; Cristina Rodriguez; Ignacio Fernández-Urien; Francisco J Jiménez
Journal:  World J Gastrointest Endosc       Date:  2011-03-16

6.  Outcome of endoscopic retrograde cholangiopancreatography during live endoscopy demonstrations.

Authors:  Wiriyaporn Ridtitid; Rungsun Rerknimitr; Sombat Treeprasertsuk; Pradermchai Kongkam; Christopher J L Khor; Pinit Kullavanijaya
Journal:  Surg Endosc       Date:  2012-02-21       Impact factor: 4.584

Review 7.  Should We Use High-Flow Nasal Cannula in Patients Receiving Gastrointestinal Endoscopies? Critical Appraisals through Updated Meta-Analyses with Multiple Methodologies and Depiction of Certainty of Evidence.

Authors:  Chi Chan Lee; Teressa Reanne Ju; Pei Chun Lai; Hsin-Ti Lin; Yen Ta Huang
Journal:  J Clin Med       Date:  2022-07-03       Impact factor: 4.964

8.  Risk of sedation for diagnostic esophagogastroduodenoscopy in obstructive sleep apnea patients.

Authors:  Jae Myung Cha; Jung Won Jeun; Kwan Mi Pack; Joung Il Lee; Kwang Ro Joo; Hyun Phil Shin; Won-Chul Shin
Journal:  World J Gastroenterol       Date:  2013-08-07       Impact factor: 5.742

Review 9.  Comparison of ERCP, EUS, and ERCP combined with EUS in diagnosing pancreatic neoplasms: a systematic review and meta-analysis.

Authors:  Hongyu Li; Zhigang Hu; Jiang Chen; Xiaozhong Guo
Journal:  Tumour Biol       Date:  2014-06-03

10.  Pre-existing diseases of patients increase susceptibility to hypoxemia during gastrointestinal endoscopy.

Authors:  Yanhua Long; Hui-Hui Liu; Changhong Yu; Xia Tian; Yi-Ran Yang; Cheng Wang; Yajuan Pan
Journal:  PLoS One       Date:  2012-05-22       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.